Josephine M. Vos, Nickolas Tsakmaklis, Christopher J. Patterson, Kirsten Meid, Jorge J. Castillo, Philip Brodsky, Tomas Ganz, Steven T. Pals, Marie José Kersten, Lian Xu, Guang Yang, Steven P. Treon, Zachary R. Hunter. CXCL13 levels are elevated in patients with Waldenström macroglobulinemia, and are predictive of major response to ibrutinib. Haematologica 2017;102(11):e452-e455; https://doi.org/10.3324/haematol.2017.172627.